These findings suggested that changes in the promoter methylation status of HLA-DRB1 and HLA-DQB1 are tightly associated with Kazakh ESCC progression and could serve as cancer biomarkers. This evidence concerns the gene HLA-DRB1 and esophageal squamous cell carcinoma.